Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study

M. H. J. van Oers; A. Hagenbeek; M. van Glabbeke; I. Teodorovic

doi:https://doi.org/10.1007/s00277-002-0548-2

Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study

M. H. J. van Oers, A. Hagenbeek, M. van Glabbeke, I. Teodorovic

Clinical Haematology (AMC)

Research output: Contribution to journal › Article › Academic › peer-review

5 Citations (Scopus)

Original language	English
Pages (from-to)	553-557
Journal	Annals of Hematology
Volume	81
Issue number	10
DOIs	https://doi.org/10.1007/s00277-002-0548-2
Publication status	Published - 2002

Access to Document

https://doi.org/10.1007/s00277-002-0548-2

Cite this

van Oers, M. H. J., Hagenbeek, A., van Glabbeke, M., & Teodorovic, I. (2002). Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study. Annals of Hematology, 81(10), 553-557. https://doi.org/10.1007/s00277-002-0548-2

@article{8572091cd1c347cdbf5bc5948e9341b8,

title = "Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study",

author = "{van Oers}, {M. H. J.} and A. Hagenbeek and {van Glabbeke}, M. and I. Teodorovic",

year = "2002",

doi = "https://doi.org/10.1007/s00277-002-0548-2",

language = "English",

volume = "81",

pages = "553--557",

journal = "Annals of Hematology",

issn = "0939-5555",

publisher = "Springer Verlag",

number = "10",

}

van Oers, MHJ, Hagenbeek, A, van Glabbeke, M & Teodorovic, I 2002, 'Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study', Annals of Hematology, vol. 81, no. 10, pp. 553-557. https://doi.org/10.1007/s00277-002-0548-2

Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study. / van Oers, M. H. J.; Hagenbeek, A.; van Glabbeke, M. et al.
In: Annals of Hematology, Vol. 81, No. 10, 2002, p. 553-557.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study

AU - van Oers, M. H. J.

AU - Hagenbeek, A.

AU - van Glabbeke, M.

AU - Teodorovic, I.

PY - 2002

Y1 - 2002

U2 - https://doi.org/10.1007/s00277-002-0548-2

DO - https://doi.org/10.1007/s00277-002-0548-2

M3 - Article

C2 - 12424535

SN - 0939-5555

VL - 81

SP - 553

EP - 557

JO - Annals of Hematology

JF - Annals of Hematology

IS - 10

ER -